). Four weeks of inhalation of 100 ppm EO caused a significant increase in K-ras codon 12 GGT→GTT MF relative to controls, whereas 50, 100, and 200 ppm EO caused significant increases in K-ras codon 12 GGT→GAT MF. In addition, significant inverse correlations were observed between K-ras codon 12 GGT→GTT MF and cII mutant frequency in the lungs of the same mice exposed to 50, 100, or 200 ppm EO for 4 weeks. Surprisingly, 8 weeks of exposure to 100 and 200 ppm EO caused significant decreases in K-ras MFs relative to controls. Thus, the changes in K-ras MF as a function of cumulative EO dose were nonmonotonic and were consistent with EO causing early amplification of preexisting K-ras mutations, rather than induction of K-ras mutation through genotoxicity at codon 12. The possibility that these changes reflect K-ras mutant cell selection under varying degrees of oxidative stress is discussed.
Ethylene oxide (EO) is an intermediate in the production of industrial chemicals and is among the top 25 highest production volume chemicals (NTP, 2011) . Most human exposure to EO is through its use as a disinfectant in hospitals and the medical equipment industry, replacing steam sterilization of heat-sensitive tools and equipment (IARC, 1994; NTP, 2011; Recio et al., 2004) .
EO has been classified as a Group 1 carcinogen by IARC based on limited evidence in humans and sufficient evidence in experimental animals for its carcinogenicity (IARC, 2008) . In making this evaluation, the agency has considered, among other things, biomonitoring studies showing increased frequencies of chromosomal aberrations and sister chromatid exchanges in the peripheral lymphocytes of exposed workers combined with prospective studies associating elevated levels of chromosomal aberrations with increased risk for cancers (IARC, 2008) . Furthermore, EO has been shown to act as a mutagen and/or clastogen both in somatic and germ cells of experimental animals (reviewed in IARC, 2008) . For example, chromosomal aberrations and reciprocal translocations have also been observed in the peripheral lymphocytes of B6C3F 1 mice (Donner et al., 2010) . In addition, increases in the frequency of micronucleated alveolar type II cells and Clara cells were observed in mice following inhalation of 630 mg/m 3 EO for 4 h (Lindberg et al., 2010) . A 2-year bioassay in B6C3F 1 mice using inhaled concentrations of 50 and 100 ppm EO found significant increases in several different tumor types in male and female mice. In male mice, the incidence of alveolar/brochiolar carcinomas of the lung (100 ppm) and Harderian gland tumors (50 and 100 ppm) significantly increased with EO exposure, whereas in female mice, the incidence of alveolar adenoma (100 ppm), alveolar/brochiolar carcinoma (100 ppm), lymphoma (100 ppm), Harderian gland tumors (100 ppm), mammary tumors (50 ppm), and uterine tumors (100 ppm) increased significantly with EO exposure (NTP, 1988) . In male mice, combined alveolar/bronchiolar adenoma or carcinoma incidences were 11/50 (22%), 19/50 (38%), and 26/50 (52%) in the 0-, 50-, and 100-ppm groups, respectively.
EO can "react directly with cellular macromolecules, including DNA, causing gene mutations and chromosome deletions in somatic cells" (Sisk et al., 1997) , and its reactivity may be an intrinsic part of EO's mode of action (MOA) for lung carcinogenicity. EO primarily produces N7-(2-hydroxyethyl)guanine (7-HEG) adducts (Walker et al., 1990 ). An in vitro study of EO-DNA interaction found that 7-HEG, N3-(2-hydroxyethyl) adenine (3-HEA), and O 6 -(2-hydroxyethyl)guanine were formed with ratios of 100:4.4:0.5, respectively (Segerback, 1990; Van Delft et al., 1991) . 7-HEG and 3-HEA can spontaneously depurinate (Brookes and Lawley, 1963; Koskinen and Plna, 2000) . Transfected, 7-HEG adducted DNA was described as "intrinsically nonmutagenic provided the apurinic sites that may form spontaneously are removed prior to introduction of the plasmids into the cells" (Fuchs et al., 2011) . Apurinic sites are potentially resolved by base-excision repair (BER). EO exposure induces BER enzymes (N3-methyladenine-DNA glycosylase, 8-oxoguanine DNA glycosylases, AP endonuclease, alkylguanine methyltransferase, and polymerase β) (Rusyn et al., 2005) . Although adenine is usually inserted opposite apurinic sites in prokaryotic cells (Pages et al., 2008) , mutational specificities expected from abasic sites in mammalian cells are unclear and may depend upon the polymerases involved in repair Eoff et al., 2010; Klinedinst and Drinkwater, 1992; Neto et al., 1992) . Given the stability of O 6 -alkylG:T replicative intermediates, -(2-hydroxyethyl)guanine may result in G:C→A:T mutations (Ashby et al., 1982; Mazon et al., 2010) .
Oxidative stress leading to the induction of 8-oxo-2′-deoxyguanosine (8-oxo-dG) adducts with subsequent production of G:C→T:A mutations is another potential mechanism in the etiology of EO-induced lung tumors. EO undergoes detoxification by conjugation with glutathione (GSH), as well as hydrolysis by epoxide hydrolase, and causes significant GSH depletion within 4 h of exposure to 100 ppm EO (Brown et al., 1998; McKelvey and Zemaitis, 1986) . In fact, it has been suggested that GSH depletion may play an important role in determining the susceptibility of mice to EO-induced lung tumor development (Brown et al., 1998) . A decrease in the reactive oxygen species (ROS)-scavenging capacity of a cell, such as that caused by GSH depletion, can disrupt redox homeostasis and cause an overall increase in intracellular ROS levels (Trachootham et al., 2008) . Therefore, oxidative stress has the potential to cause accumulation of 8-oxo-dG adducts, with consequent induction of G:C→T:A mutations (Shibutani et al., 1991; Valavanidis et al., 2009) .
Several studies reported induction of Hprt mutation in EO-exposed rodents (Tates et al., 1999; Van Sittert et al., 2000; Walker et al., 2000) . A significant 1.5-fold increase in lacI mutant frequency was observed in lung DNA of transgenic B6C3F 1 mice exposed to 200 ppm EO for 4 weeks and examined 4 weeks later (Sisk et al., 1997) . Significant increases in lacI mutation were detected in bone marrow following 48 weeks of inhalation of 100 and 200 ppm EO and in testes following 48 weeks of inhalation of 25, 50, and 100 ppm EO but not following 200 ppm EO inhalation (Recio et al., 2004) . In addition, this study found a significant increase in A:T→T:A mutation in bone marrow of EO-treated mice although a similar pattern of A:T→T:A mutation was not detected in testes.
A comprehensive study, including multiple endpoints, was designed to elucidate EO's carcinogenic MOA (Supplementary Figure S1) . Quantification of K-ras mutation was included because all 23 of the lung tumors that were evaluated from EO-exposed mice in the NTP cancer bioassay had K-ras mutations, indicating that K-ras mutation is likely a key event in EO-induced lung carcinogenesis (Hong et al., 2007) . Analyses of 3 different K-ras codon 12 mutations were undertaken in order to test the specific hypothesis that EO causes oxidative stress in mouse lung, leading to the production of 8-oxo-dG adducts at the second position of K-ras codon 12, which result in the GGT→GTT mutations observed in 21/23 (91%) of the EO-induced lung tumors that were evaluated from EO-exposed mice (Hong et al., 2007) . Because 8-oxo-dG DNA adducts preferentially generate G:C→T:A mutations, an early and preferential increase of the GGT→GTT mutation relative to GGT→GAT mutation would support the aforementioned hypothesis. Alternatively, early induction of K-ras codon 12 GGT→GAT mutation, to an extent equal to or greater than the K-ras codon 12 G:C→T:A mutations (GGT→GTT and/ or GGT→TGT), would support the idea that K-ras codon 12 GGT→GTT tumor mutations are created via an indirect mechanism involving amplification of cells containing preexisting mutations. Amplification of preexisting mutation had been demonstrated previously using a sensitive allele-specific amplification method. Specifically, clonal expansion of preexisting H-ras codon 12 GGA→GAA mutation in mammary tissue of rats treated with N-nitroso-N-methylurea was observed using the mismatch amplification mutation assay (Cha et al., 1994) . Therefore, ACB-PCR was used to quantify K-ras codon 12 GGT→GAT, GGT→GTT, and GGT→TGT mutations in lung DNA samples from mice exposed for 4 weeks to 0, 10, 50, 100, or 200 ppm EO or for 8 or 12 weeks to 0, 100, or 200 ppm EO.
MATERIALS AND METhODS
Study design. This work was part of a broader investigation aimed at evaluating the alternative hypotheses of an oxidative stress-related or directly mutagenic MOA for EO-induced lung carcinogenesis (Supplementary Figure  S1) . The effect of EO inhalation was examined in the lung tissue of 12-to 16-week-old mice, ages at which other studies have found relatively low, but measureable levels of cell proliferation in untreated controls (Kanno et al., 1993; Yu et al., 2002) . Results describing EO-induced lung histopathology, DNA strand breaks, DNA adducts, markers of oxidative stress, ROS, and cII mutation will be published separately, with time and dose concordance between endpoints integrated into a MOA analysis. use activities were reviewed and approved by the Institutional Animal Care and Use Committee in accordance with the U.S. Department of Agriculture Animal Welfare Regulations, 9 CFR, Subchapter A, Parts 1-4. The mice were exposed to EO by inhalation, 6 h/day, 5 days/week for 4 weeks using target concentrations of 0, 10, 50, 100, or 200 ppm EO, or were exposed for 8 or 12 weeks using target concentrations of 0, 100, or 200 ppm EO. Mean, analytically determined, chamber concentration values (± SD) for the 0-, 10-, 50-, 100-, and 200-ppm EO exposure chambers were 0, 10.1 ± 0.4, 50.0 ± 1.6, 100.5 ± 4.6, and 199.2 ± 2.7 ppm, respectively. The nominal concentrations, determined by the mass of EO divided by volume of gas delivered, were 10.0 ± 0.2, 51.5 ± 0.4, 104.0 ± 7.7, and 206.5 ± 0.9 ppm for the 10-, 50-, 100-, and 200-ppm exposure chambers, respectively. Unexposed and EO-treated mice were sacrificed and lungs were removed and snap-frozen in liquid nitrogen and shipped to the National Center for Toxicological Research on dry ice for subsequent DNA isolation and mutation analyses. The left lobe was used for ACB-PCR analysis and the right lobe for cII mutation analysis, thereby enabling comparisons of a neutral transgene mutant frequency with the endogenous K-ras mutant fraction (MF) within the same mouse.
Isolation of lung DNA for ACB-PCR. DNA was isolated from the entire left lobe of each mouse lung to reduce the potential for sampling errors due to mutation being heterogeneously distributed across the tissue. To isolate highmolecular-weight genomic DNA, lung tissues were minced, then homogenized in 1 ml of an extraction buffer consisting of 1 mg/ml proteinase K, 100mM NaCl, 25mM EDTA, pH 8.0, and 1% SDS. Samples were incubated approximately 16 h at 37°C, extracted with an equal volume of phenol/chloroform/ isoamyl alcohol (25:24:1), and ethanol precipitated. Samples were resuspended in 200 µl of RNAse buffer: 10 mg/ml RNAse A (Sigma, St Louis, Missouri), 600 units/ml Ribonuclease T1 (Sigma), 100mM sodium acetate, and 50mM Tris-HCl (pH 8.0), incubated approximately 16 h at 37°C, then extracted as described above. Each DNA sample was ethanol precipitated, then resuspended in 20 µl of TE buffer (5mM Tris, 0.5mM EDTA, pH 7.5). DNA samples were digested with HindIII according to the manufacturer's instructions (New England Biolabs, Beverly, Massachusetts). Finally, the DNA was extracted as described above, ethanol precipitated, and resuspended in 40 µl of TE buffer.
Preparation of standards and unknowns by first-round PCR amplification. Amplification of a K-ras gene segment was performed using PfuUltra hotstart high-fidelity DNA polymerase (Stratagene, La Jolla, California) in order to (1) synthesize MF standards using linearized plasmid DNA as template and (2) to generate a product from each HindIII-digested genomic DNA sample isolated from lung tissues. HindIII-digested lung DNA was used for first-round PCR amplification of a 170 bp K-ras gene segment encompassing part of the 5′-untranslated region of exon 1 and part of intron 1 (NC_000072 region: 29 950-30 119). Each 200 µl PCR reaction contained 1 µg genomic DNA (corresponds to 3 × 10 5 copies of a single copy nuclear gene), 200nM primer TR67 (5′-TGGCTGCCGTCCTTTACAA-3′), 200nM primer TR68 (5′-GGCCTGCTGAAAATGACTGAGTATAAACTTGT-3′), 200nM dNTPs, 1× PfuUltra reaction buffer, and 10 U PfuUltra hotstart high-fidelity DNA polymerase (Stratagene). Cycling conditions were 94°C for 2 min, followed by 28 cycles of 94°C for 1 min, 58°C for 2 min, 72°C for 1 min, followed by a 7 min extension at 72°C. Primers were purchased from Integrated DNA Technologies, Coralville, Iowa.
Purification and quantification of PCR products. The PCR products (standards and unknowns) were purified by ion-pair reverse phase chromatography using a WAVE Nucleic Acid Fragment Analysis System (Transgenomic Inc, Omaha, Nebraska). PCR products were complexed with 0.1 M triethylammonium acetate (Buffer A: 0.1 M TEAA) and bound to a DNASep column (containing C18 alkylated PS/DVB polymer). PCR products, input template, unincorporated nucleotides, and primers were eluted using a gradient of increasing acetonitrile concentration (Buffer B: 0.1 M TEAA, 25% acetonitrile), in which nucleic acids were separated by size/column retention time. A threshold collection method was used to collect the 170 bp PCR products (based on their absorbance at 260 nm measured with a UV detector at the appropriate retention time) into individual tubes in a chilled fraction collector (Transgenomic, . PCR products were evaporated to dryness using a Savant Speed-Vac Concentrator (Model ISS110, ThermoFisher Scientific, Rockville, Maryland). PCR products were resuspended in TE buffer and multiple 2-µl aliquots were prepared and stored at −80°C. Multiple aliquots were repeatedly quantified using an Epoch Micro-Volume Spectrophotometer System with a Take3 Microplate Reader (Biotek Instruments, Winooski, Vermont), until 3 measurements that varied by less than 10% from the group mean were obtained.
ACB-PCR quantification of K-ras codon 12 GGT→GTT, GGT→GAT, and GGT→TGT MFs. ACB-PCR is an allele-specific amplification method that can be used to selectively amplify and quantify a mutant allele in a 100 000-fold excess of wild-type allele (see Supplementary Figure S2 for an example of an ACB-PCR priming strategy). ACB-PCR quantification is based on the analysis of equal numbers of molecules of first-round PCR product generated from unknown samples and standards that have defined ratios of mutant:WT DNA (ie, MF standards). The first-round PCR products generated from the lung DNA samples were identical in sequence composition to the MF standards. Purified first-round PCR products of mutant and WT DNA samples (generated using plasmid templates) were mixed to generate standards with MFs of 10 −1 , 10 −2 , 10 −3 , 10 −4 , 10 −5 , and 0. The no-mutant controls (MF of 0) established the ACB-PCR signal generated from the WT standard, which defines the technical background of each assay. Duplicate MF standards and a no-DNA control were included in each assay. For the ACB-PCR analysis of all 3 mutations, 5 × 10 8 copies were analyzed in 50 µl reactions performed in 96-well plates using a DNA Engine Tetrad 2 (Bio-Rad Life Science Research, Hercules, California).
For quantification of K-ras codon 12 GGT→GTT mutation, each ACB-PCR reaction contained 1× Stoffel buffer, 0.1 mg/ml gelatin, 1 mg/ml Triton X-100, 40µM dNTPs, 1.5mM MgCl 2 , 480nM mutant-specific primer (TR87, 5′-fluorescein-CTTGTGGTGGTTGGAGCTAT-3′), 600nM blocker primer (TR77, 5′-CTTGTGGTGGTTGGAGCTAG-phosphate-3′), and 400nM upstream primer (TR73, 5′-TCGTAGGGTCGTACTCATC-3′). Each reaction was initiated with the addition of 100 ng of extreme thermostable single-stranded DNA binding protein (New England Biolabs), 90 mU of PerfectMatch PCR enhancer (Stratagene), and 1.67 U of a hotstart formulation of Stoffel DNA polymerase, which was prepared by incubating Taq DNA polymerase Stoffel fragment (Life Technologies, Grand Island, New York) with Platinum Taq antibody (Life Technologies) at a 1:1 unit ratio on ice for 30 min. Cycling conditions were 2 min at 94°C, followed by 36 cycles of 94°C for 30 s, 41°C for 45 s, and 72°C for 1 min. The K-ras codon 12 GGT→GTT ACB-PCR product is 91 bp in length.
For quantification of K-ras codon 12 GGT→GAT mutation, each ACB-PCR reaction contained 1× Stoffel buffer, 0.1 mg/ml gelatin, 1 mg/ml Triton X-100, 80µM dNTPs, 1.6mM MgCl 2 , 300nM mutant-specific primer (TR76, 5′-fluorescein-CTTGTGGTGGTTGGAGCTAA-3′), 525nM blocker primer (TR77, 5′-CTTGTGGTGGTTGGAGCTAG-phosphate-3′), and 300nM upstream primer (TR73, 5′-TCGTAGGGTCGTACTCATC-3′). Each reaction was initiated with the addition of 165 ng of extreme thermostable single-stranded DNA binding protein, 60 mU of PerfectMatch PCR Enhancer, and 1.67 U of the hotstart formulation of Stoffel DNA polymerase. Cycling conditions were 2 min at 94°C, followed by 36 cycles of 94°C for 30 s, 45°C for 45 s, and 72°C for 1 min. The K-ras codon 12 GGT→GAT ACB-PCR product is 91 bp in length.
For quantification of K-ras codon 12 GGT→TGT mutation, each ACB-PCR reaction contained 1× Stoffel buffer, 0.1 mg/ml gelatin, 1 mg/ml Triton X-100, 60µM dNTPs, 1.5mM MgCl 2 , 250nM mutant-specific primer (TR75, 5′-fluorescein-ACTTGTGGTGGTTGGAGCCT-3′), 400nM blocker primer (TR77, 5′-ACTTGTGGTGGTTGGAGCCdG-3′), and 250nM upstream primer (TR73, 5′-TCGTAGGGTCGTACTCATC-3′). Each reaction was initiated with the addition of 100 ng of extreme thermostable single-stranded DNA binding protein, 250 mU of PerfectMatch PCR Enhancer, and 3.33 U of the hotstart formulation of Stoffel DNA polymerase. Cycling conditions were 2 min at 94°C, followed by 36 cycles of 94°C for 30 s, 41°C for 45 s, and 72°C for 1 min. The K-ras codon 12 GGT→TGT ACB-PCR product is 92 bp in length.
Gel electrophoresis and quantification of ACB-PCR products.
Because each mutant-specific primer is labeled with a 5′-fluorescein molecule, ACB-PCR products can be quantified based on the fluorescence of the correctsized band following vertical polyacrylamide gel electrophoresis. Following ACB-PCR, 10 µl of bromophenol blue/xylene cyanol-containing 6× Ficoll loading dye was added to each well of the 96-well plate. Then, 10 µl of ACB-PCR reaction products were analyzed on 8% nondenaturing polyacrylamide gels, along with a fluorescent DNA length marker. Fluorescent bands were visualized using a PharosFX scanner with an external blue laser (Bio-Rad). Pixel intensities of the bands were quantified using Quantity One software, using a locally averaged background correction (Bio-Rad).
Data analyses. The pixel intensities determined for the MF standards were plotted against their MFs on log-log plots. A trend line (power function) was fitted to the data, and the MF in each unknown sample was calculated using the formula of the concurrent standard curve and the pixel intensity measured in the sample. The arithmetic average of the 3 independent MF measurements was calculated. The average MF in each lung DNA sample was log transformed and the average log-transformed MF for the 10 mice in each treatment group was calculated. This value, converted back to MF, is the geometric mean MF for each treatment group. Because many of the measurements were below the limit of accurate ACB-PCR quantification (10 −5 ) (McKinzie and Parsons, 2002) , the statistical significance of treatment effects was assessed by comparing the distribution of samples above and below 10 −5 for a particular treatment group with that of the concurrent control group, using a 2-sided Fisher's exact test (GraphPad Prism 5, GraphPad Software, Inc, La Jolla, California). Pearson's rank correlation coefficient was calculated on log-transformed data, using a 2-tailed test to examine correlations between mutant frequency at the cII locus and K-ras MFs, which were also examined by linear regression using GraphPad software.
RESuLTS
The ACB-PCR analyses of the 110 mouse lung DNA samples were performed for mice treated in 3 separate groups: 50 mice exposed for 4 weeks (10 each exposed to 0, 10, 50, 100, and 200 ppm EO), 30 mice exposed for 8 weeks (10 each exposed to 0, 100, and 200 ppm EO), and 30 mice exposed for 12 weeks (10 each exposed to 0, 100, and 200 ppm EO). For each sample, 3 independent ACB-PCR measurements were collected using 3 separate aliquots of first-round PCR product, each analyzed along with a unique set of MF standards. Examples of the polyacrylamide gel images of ACB-PCR products are shown for the K-ras codon 12 GGT→GTT and GGT→GAT mutations in Supplementary Figures S3 and S4 , respectively. A survey of the data found no MF measurements greater than 10 −2 , meaning all quantifiable, unknown measurements were within the range between 10 −5 and 10 −2
. Initial analyses of the GGT→GTT MF data found that the standard deviation among replicate measurements and the coefficients of determination for the standard curves were improved when only MF standards 10 −2 through 10 −5 were used to construct the standard curves (rather than MF standards 10 −1 through 10 −5
). Consequently, all subsequent analyses omitted the 10 −1 standards. Examples of standard curves constructed using MF standard measurements are shown in Supplementary Figure S5 .
K-ras codon 12 GGT→GTT, GGT→GAT, and GGT→TGT MF measurements determined for each individual mouse lung DNA sample are shown in Supplementary Figures S6-S8 , respectively.
K-ras Codon 12 GGT→GTT MF Measurements
The average coefficient of determination for the K-ras codon 12 GGT→GTT standard curves was 0.9825 (range 0.9517-0.9968). The average coefficients of variation for the triplicate GGT→GTT MF measurements of samples exposed for 4, 8, and 12 weeks were 0.56, 0.80, and 0.94, respectively.
The average K-ras codon 12 GGT→GTT MF measurement for each individual mouse lung DNA sample is shown for mice exposed to EO for 4 weeks (Fig. 1A) , 8 weeks (Fig. 1B) , and 12 weeks (Fig. 1C) . The horizontal line indicates the median MF for each group and the shaded area in each plot highlights measurements below 10 −5 , the lower limit of accurate ACB-PCR quantification. Because many MF measurements were below 10 −5 , statistically significant differences among treatment groups were identified by comparing distributions of K-ras MFs greater than and less than 10 −5 , using a 2-sided Fisher's exact test. For each treatment group, Table 1 reports the K-ras codon 12 GGT→GTT geometric mean MF (geomean), the median MF, the number of samples in each treatment group with MFs greater than and less than 10 −5 , and the significance of the distribution compared with controls. Regarding samples exposed to EO for 4 weeks, Figure 1A and Table 1 show that the median K-ras codon 12 GTT MF increased with EO concentration up to 50 ppm. The median K-ras codon 12 GTT MFs in the 50-and 100-ppm EO treatment groups were similar but decreased in the 200-ppm EO treatment group. In addition, the 100-ppm EO treatment group had a significantly larger number of samples with MFs greater than 10 −5 compared with the control group. Surprisingly, in lung DNA samples from mice exposed for 8 weeks, a significant number of samples in the 100-and 200-ppm treatment groups had K-ras codon 12 GGT→GTT MFs less than 10 −5 compared with the concurrent control group (Fig. 1B and Table 1 ). Following 12 weeks of exposure, the number of samples with K-ras codon 12 GGT→GTT MFs greater than 10 −5 was significantly less in the 200-ppm treatment group compared with the concurrent control group (Fig. 1C and Table 1 ). Thus, the initial significant increase in K-ras codon 12 GGT→GTT MF observed following 4 weeks of exposure (100 ppm) was followed by significant loss of the mutation with longer duration exposures and higher cumulative doses.
K-ras Codon 12 GGT→GAT MF Measurements
The average coefficient of determination for the K-ras codon 12 GGT→GAT standard curves was 0.9813 (range 0.9560-0.9955). The average coefficients of variation for the triplicate GGT→GAT MF measurements of samples exposed for 4, 8, or 12 weeks were 0.40, 0.74, and 0.80, respectively. It should be noted that for 1 sample (no. 88) in the 12-week, 0-ppm treatment group, 1 of the 3 calculated K-ras codon 12 GGT→GAT MF measurements was a negative number and, 29 therefore, deemed a technical failure. Consequently, only 2 K-ras codon 12 GGT→GAT MF measurements were obtained for this sample.
The average K-ras codon 12 GGT→GAT MF measurement for each individual mouse lung DNA sample is shown for mice exposed to EO for 4 weeks (Fig. 1D), 8 weeks (Fig. 1E) , and 12 weeks (Fig. 1F) . Table 2 reports the K-ras codon 12 GGT→GAT geomean, the median MF, the number of samples in each treatment group with MFs greater than and less than 10 −5
, and the significance of the distribution compared with controls. Figure 2A and Table 2 show that following 4 weeks of EO exposure, the K-ras codon 12 GGT→GAT median MFs increased with concentrations up to 50 ppm, but then decreased slightly at 100 and 200 ppm. In addition, the 50-, 100-, and 200-ppm EO treatment groups each had a significantly larger number of samples with MFs greater than 10 −5 compared with the concurrent control group. Similar to what was seen for the GGT→GTT MF measurements, at 8 weeks, a significant number of samples in the 100-and 200-ppm treatment groups had K-ras codon 12 GGT→GAT MFs less than 10 −5 compared with
FIG. 1.
Analysis by treatment group of the K-ras codon 12 GGT→GTT and GGT→GAT mutant fractions (MFs) measured in each animal. For each treatment group, the horizontal bar indicates the median MF. K-ras codon 12 GGT→GTT MFs measured in samples exposed for 4, 8, or 12 weeks are presented in (A-C), respectively. K-ras codon 12 GGT→GAT MFs measured in samples exposed for 4, 8, or 12 weeks are presented in (D-F), respectively. Asterisks denote statistical significance of the distribution of samples greater than and less than 10 −5 with respect to the concurrent control group. Data points in the shaded area are considered below the limit of accurate ACB-PCR quantification. the concurrent control group (Fig. 2B and Table 2 ). No significant differences in K-ras codon 12 GGT→GAT MF were observed among treatment groups exposed to EO for 12 weeks.
K-ras Codon 12 GGT→TGT MF Measurements
The average coefficient of determination for the K-ras codon 12 GGT→TGT standard curves was 0.9664 (range 0.9277-0.9886). The average coefficients of variation for the triplicate GGT→TGT MF measurements of samples exposed for 4, 8, and 12 weeks were 1.18, 1.03, and 0.84, respectively. No sample had a K-ras codon 12 GGT→TGT MF greater than 10 −5 ; consequently, no statistical analyses were performed on the K-ras codon 12 GGT→TGT MF measurements.
Time-Dependent and EO Concentration-Dependent
Changes in K-ras MF Figure 2 shows that there were generally higher levels of the K-ras codon 12 GGT→GAT mutation than GGT→GTT mutation in both treated and control samples. A surprising amount of variability was observed among the control groups on study for different lengths of time, with higher levels of both mutations present at 8 weeks compared with 4 weeks and then subsequent decreases in both MFs to intermediate values at 12 weeks (Fig. 2) . Among control mice, the distribution of mice with K-ras codon 12 GGT→GTT MFs greater than and less than 10 −5 was significantly different at 8 weeks from that observed at 4 weeks (Table 3 and Fig. 2A ). For the GGT→GAT mutation in control mice, the distribution of mice with MFs greater than and less than 10 −5 was significantly different at 8 and 12 weeks from that observed at 4 weeks (Table 4 and Fig. 2B) .
Figures 3A and 3B show the changes in median MF over the duration of treatment for each EO concentration group for the K-ras codon 12 GGT→GTT and GGT→GAT MFs, respectively. At 8 weeks, when the levels of both K-ras mutations increased in control mice, sharp decreases in K-ras MF were observed in the lung DNAs of mice exposed to 100 or 200 ppm EO. Figures 3C and 3D show the changes in K-ras codon 12 GGT→GTT and K-ras codon 12 GGT→GAT median MF as a function of cumulative EO dose.
Correlation Between K-ras Codon 12 GGT→GTT and GGT→GAT MF Measurements
The correlation between the 2 different K-ras MF measurements within individual tissue samples was analyzed. The quantifiable levels of the 2 mutations (ie, MFs > 10 −5 ) were significantly correlated (p < .0001, r = 0.7655). The K-ras codon 12 GGT→GTT and GGT→GAT MF measurements within individual lung DNA samples are plotted in Figure 4 , which shows samples with relatively high K-ras codon 12 GGT→GTT MFs also had relatively high K-ras codon 12 GGT→GAT MFs.
Correlation Between cII Mutant Frequency and K-ras Codon 12 MF
It was of interest to determine whether correlations between cII and K-ras mutational measurements from the same lung samples could be identified. Because cII mutant
FIG. 2.
Age-and dose-related changes in median K-ras codon 12 GGT→GAT and GGT→GTT mutant fractions (MFs). Data points in the shaded area are considered below the limit of accurate ACB-PCR quantification. frequency (data to be published separately) increased significantly with concentration at 8 and 12 weeks, it was apparent that these measurements would not correlate with K-ras MF measurements. Consequently, relationships between cII and K-ras were analyzed using only the data from mice exposed to EO for 4 weeks. Log10 cII mutant frequencies were plotted relative to the log10 K-ras codon 12 GGT→GTT MFs and GGT→GAT MFs ≥ 10 −5 (the limit of accurate ACB-PCR quantification) measured in lung DNA samples of individual mice (Supplementary Figures  S9A and S9B , respectively). Significant negative correlations were observed between cII mutant frequencies and K-ras codon 12 GGT→GTT MFs, with the strength of the negative correlation increasing with increasing EO exposure concentration (r = −0.4964 using combined data from the 50-, 100-, and 200-ppm treatment groups and r = −0.9642 using data from only the 200-ppm treatment group; Figs. 5A and 5B, respectively). Thus, among highly EO-exposed samples, those with high cII mutant frequencies had low K-ras codon 12 GGT→GTT MFs.
TABLE 3 K-ras Codon 12 GGT→GTT Spontaneous MF Summary Data and Statistical Analysis

TABLE 4 K-ras Codon 12 GGT→GAT Spontaneous MF Summary Data and Statistical Analysis
DISCuSSION
This work is part of a broader study to identify the key events involved in EO induction of lung tumors in mice. KRAS mutations are important drivers of human lung cancer (detected in 16% of human lung tumors by DNA sequencing, COSMIC database v65) (Bamford et al., 2004) , and K-ras mutations were found in all lung tumors evaluated from EO-exposed mice in a previous cancer study (Hong et al., 2007) . These observations suggested that an increase in K-ras mutation would likely be an early key event in EO-induced mouse lung carcinogenesis. Because K-ras codon 12 GGT→GTT mutation was detected in 21/23 EO-induced lung tumors, another goal was to investigate the hypothesis that the K-ras codon 12 GGT→GTT mutations observed in EO-induced lung tumors arose through genotoxicity involving formation of 8-oxo-dG adducts at the second position of K-ras codon 12. Given that 8-oxo-dG adducts are expected to produce G:C→T:A mutations, a specific early increase in K-ras codon 12 GGT→GTT and/or GGT→TGT mutation (relative to K-ras codon 12 GGT→GAT mutation) would substantiate this hypothesis.
In fact, an early induction of both K-ras codon 12 GGT→GAT and GGT→GTT mutations was observed, with greater induction of the GGT→GAT mutation. This observation, along with several additional types of evidence, is consistent with EO primarily causing early amplification of preexisting K-ras mutations rather than induction of K-ras mutation through genotoxicity at codon 12. First, induction of K-ras codon 12 GAT mutation can be viewed as induction of a common spontaneous mutation. This is supported by data from spontaneous mouse lung tumors, where 27/108 tumors had a K-ras mutation, with 41% showing codon 12 GAT and 4% GTT (Hong et al., 2007) . Second, if EO induced K-ras mutation by a direct mutagenic MOA (ie, by conversion of DNA adducts to mutations), it should be possible to discern a consistent relationship between the appearance of DNA adduct(s) and the appearance of induced mutations although direct concordance at any particular dose/time point may be impacted by induction of DNA repair. Individually, none of the adducts or DNA damage reportedly induced by O 6 -(2-hydroxyethyl)guanine] can explain the observed increases in both K-ras mutations, with GGT→GAT induced to a greater extent than GGT→GTT. It could, however, be postulated that a combination of different types of DNA damage could lead to the profile of induced K-ras mutation observed following 4 weeks of treatment [eg, 8-oxo-dG combined with O 6 -(2-hydroxyethyl)guanine]. Consequently, it cannot be ruled out from the ACB-PCR analyses that some K-ras mutation resulted from EO-induced genotoxicity. Third, in conjunction with higher spontaneous levels of K-ras codon 12 GGT→GAT relative to GGT→GTT mutation, we observed that the induction of the 2 mutations was correlated within individual mice (Fig. 5) . These results are interpreted as supporting a mechanism of EO-induced lung carcinogenesis that involves early amplification of preexisting K-ras mutation.
Following 4 weeks of treatment, 50 ppm EO was the lowest concentration to produce a statistically significant increase in K-ras codon 12 GGT→GAT mutation although the increase in K-ras codon 12 GGT→GAT mutation induced by 10 ppm EO was significant at the 94% confidence level (p = .0573). Consequently, K-ras codon 12 GGT→GAT mutation was significantly increased at an early time point using EO concentrations at (100 ppm) or below (50 ppm) those shown to significantly increase lung tumors in a mouse tumor bioassay (NTP, 1988) . These results add to the body of evidence indicating that ACB-PCR measurement of oncogene mutation is a sensitive early indicator of carcinogenic effect (Parsons et al., 2010) .
A novel finding of this study is that K-ras codon 12 GGT→GTT and GGT→GAT MFs did not accumulate straightforwardly with cumulative EO dose or duration of treatment. Instead, a biphasic K-ras mutational response was observed, with induction of K-ras mutation after a relatively short duration exposure (4 weeks) and low cumulative EO doses (≤ 12 000 ppm-h), but with loss of K-ras mutation with longer duration exposures and higher cumulative EO doses (Fig. 3) . The frequency of both mutations decreased in the 4-week, 200-ppm treatment group compared with lowerconcentration groups, and the control groups had the highest frequencies of mutation-positive animals after 8 or 12 weeks of study. Thus, K-ras mutants induced by 4 weeks of exposure were lost during longer periods of exposure and/or larger cumulative doses (Fig. 3) . Because no induction of cytotoxicity or apoptosis was detectable (LeBaron et al., 2012) , selective senescence or death of K-ras mutant cells must have occurred as a consequence of relatively high EO concentration and/or long duration exposures. Because the loss of mutant cells detected by ACB-PCR is in the range of approximately 1 in 10 000 to 1 in 100 000 cells relative to K-ras wild-type cells, such losses would not necessarily be detectable by histological examination. The observations that K-ras MF was inversely proportional to mutant frequency in the neutral reporter gene (cII) in DNA samples from the same mice (Fig. 5A ) and the strength of the association increased with increasing EO concentration (Fig. 5B) provide additional support for the idea that a negative selection against K-ras mutant cells occurred at high cumulative EO doses and that EO's effect on K-ras is nongenotoxic in nature.
The selective advantage conferred by Ras mutation (positive or negative) may be linked to the redox state of the cell. Binding of a negatively charged ligand to Ras protein is a potential mechanism to activate Ras signaling. S-nitrosylation of Ras by nitric oxide increased MAP kinase signaling (Lander et al., 1997) . Also, a complex of 8-oxoguanine DNA glycosylase and its excision product (8-oxoguanine) can bind Ras and induce phosphorylation of the MAP kinases MEK1,2 and ERK1,2 (Boldogh et al., 2012) . In each case, the protein FIG. 6. Hypothesized mechanism of ethylene oxide (EO)-induced Ras mutant cell selection. One potential effect of EO-induced oxidative stress is the oxidation of the guanine bases in DNA (formation of 8-oxo-dG). 8-Oxo-dG may be excised by DNA glycosylase, creating a complex that was shown to bind Ras and activate MAP kinase signaling (Boldogh et al., 2012) . Alternatively, EO may deplete glutathione, allowing formation of an as yet unidentified, negatively charged ligand that interacts with Ras. Differences in the signaling and phenotypic properties of mutant and wild-type Ras have been noted (Al-Mulla et al., 1999) . Wild-type Ras is inducible (dashed arrows), meaning that it cycles between GTP-bound and guanosine diphosphate (GDP)-bound forms, whereas the amino acid substitutions in mutant Ras diminish the Ras's ability to hydrolyze GTP. The different Ras isoforms interact preferentially with downstream effectors as depicted (Cespedes et al., 2006) . The extent of ERK activation determines cell fate. Low-level ERK activation promotes cell proliferation, whereas high levels cause growth arrest (Xu et al., 2011) . The induction of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which may result from increased MAP kinase signaling, can lead to increased levels of reactive oxygen species (Kodama et al., 2013) . This can lead to a vicious cycle of more DNA damage, with additional upregulation of K-ras and ERK signaling (blue arrows). The result could be a negative selection against K-ras mutant cells that are expected to have higher levels of ERK signaling (due to constitutive mutant signaling plus inducible wild-type signaling) than K-ras wild-type cells. Secondary G→T mutations and Ras mutant cells with a senescence associated secretory phenotype may be secondary effects that drive of EO-induced lung carcinogenesis. modification acts as a guanine nucleotide exchange factor, causing release of bound guanosine diphosphate, thereby enabling binding of guanosine triphosphate (GTP), with subsequent activation of downstream signaling. The idea that EO disrupts redox homeostasis and causes an increase of intracellular ROS levels is supported by reports that EO causes depletion of GSH (Brown et al., 1998; McKelvey and Zemaitis, 1986 ). In the current study, EO treatment caused dose-dependent increases in GSH adducts and minimal increases in ROSrelated molecules, including 8-hydroxy-2′-deoxyguanosine (LeBaron et al., 2012) . However, a significant correlation was observed between levels of 8-hydroxy-2′-deoxyguanosine and K-ras codon 12 GAT geometric mean MF in treatment groups exposed to EO for 4 weeks (data not shown). These results support the hypothesis depicted in Figure 6 that EO exposure may have caused a low level of oxidative stress and produced negatively charged molecules that modify Ras and Ras signaling. The 8-oxoguanine:OGG1 complex is shown, but other EO-induced negatively charged ligands, or EO itself, may be responsible for the observed effects on Ras.
Conversion of wild-type K-ras to the active GTP-bound conformation would be expected to augment signaling through the Raf/Mek/Erk pathway, and survival signals through the phosphoinositol-3 kinase/Pdk/Akt pathway (Guerra et al., 2003) , leading to an early expansion of K-ras mutant clones. However, there is a large body of research demonstrating a link between Ras signaling and ROS production and that the strength and duration of the ROS response determines cell fate (potentially including oncogene-induced senescence and cell death) (Burhans and Heintz, 2009; Finkel, 1999; Kodama et al., 2013; Lee et al., 1999; Mates et al., 2008; Serrano et al., 1997; Shaw et al., 2011; Weyemi et al., 2012) . Biphasic responses to EO treatment were noted previously. EO had a biphasic effect on the cell cycle in human diploid fibroblasts (Mlejnek and Kolman, 1999) . Low doses of EO transiently stimulated DNA replication, whereas higher doses caused G1/S cell cycle arrest and inhibited DNA synthesis (Mlejnek and Kolman, 1999) . The current study is the first to detect this type of biphasic response using K-ras mutation as an endpoint.
In summary, ACB-PCR was used to discern the early effects of EO on K-ras mutation in mouse lung. The results indicate that (1) the type and magnitude of induced K-ras mutations were consistent with their spontaneous occurrence in mouse lung tissue, (2) levels of K-ras codon 12 GGT→GTT and GGT→GAT mutations within individual mouse lung DNA samples were significantly correlated, (3) EO had a biphasic effect on K-ras mutation in lung tissue, and (4) K-ras mutation and cII mutation were inversely correlated in lung tissues exposed to relatively high EO doses. These data are consistent with the interpretation that EO inhalation initially alters the fitness of preexisting K-ras mutant cells rather than inducing de novo K-ras mutations in lung, although it cannot be concluded from these results that none of EO's genotoxic effects lead to K-ras mutations. The shift in K-ras tumor mutation spectrum caused by EO likely reflects selective effects on K-ras mutant clones, due to differential downstream pathway activation by the different K-ras mutants (Cespedes et al., 2006) , and interaction among clones carrying additional genetic lesions during tumor progression. One conclusion from this study is that a chemically induced shift in K-ras tumor mutational spectrum should not be regarded as conclusive evidence of mutagenesis by a chemically induced genotoxic mechanism. K-ras codon 12 GAT and GTT mutations are prevalent in normal rodent and human tissues (Parsons et al., 2010) . Consequently, the extent to which chemically induced ROS can modulate the clonal growth of preexisting ras mutants and lead to or contribute to chemical carcinogenesis is a topic that merits further investigation. 
